8329 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. engages in the research and development, production and sales of medicines, the purchase and sales of medicines, and healthcare food products. It operates through the Manufacturing and Selling of Medicines and Sales and Distribution of Medicines and Healthcare Products segments. The company was founded on November 15, 1994 and is headquartered in Hong Kong.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
8329 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company